Roles for Innate Immunity in Combination Immunotherapies
Year: 2017
Type: review
Abstract: Immunity to infectious agents involves a coordinated response of innate and adaptive immune cells working in concert, with many feed-forward and regulatory interactions between both arms of the immune system. In contrast, many therapeutic strategies to augment immunity against tumors have focused predominantly on stimulation of adaptive immunity. However, a growing appreciation of the potential contributions of innate immune effectors to antitumor immunity, especially in the context of combination immunotherapy, is leading to novel strategies to elicit a more integrated immune response against cancer. Here we review antitumor activities of innate immune cells, mechanisms of their synergy with adaptive immune responses against tumors, and discuss recent studies highlighting the potential of combination therapies recruiting both innate and adaptive immune effectors to eradicate established tumors. Cancer Res; 77(19); 5215–21. ©2017 AACR.
Source: Cancer Research
Authors: Kelly D. Moynihan, Darrell J. Irvine
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Awards: RNA circuits for cell state determination in mammalian cells in vitro and in vivo, Reprogramming the tumor microenvironment via self-amplified RNA (SafeR) circuits, Localizing Immunotherapy to Improve Therapeutic Index, Targeting immunosuppression blockade to T cells for cancer immunotherapy, Lymph node-targeted molecular vaccines, Cancer Center Support (Core) Grant
OpenAlex ID: W2754767805
